CARDIOVASCULAR COMPLICATIONS IN KOVID-19

Abstract

The 2019 coronavirus disease (KOVID-19) caused by the new coronavirus (SARS-KOV2), a severe acute respiratory syndrome, quickly developed into a global pandemic. It has caused significant mortality worldwide and is primarily associated with severe acute respiratory distress syndrome (ARDS). In addition to ARDS clinical reports have shown significant cardiovascular complications in patients with KOVID-19. Virus infection, cytokine stimulation, altered immune response, and myocardial damage are some of the mechanisms for KOVID-19 cardiovascular complications. The aim of this paper is to present the previously published medical evidence from studies and research in the world related to cardiovascular complications in conditions of infection with KOVID-19.